Evidence map›Paper›PMID 31830725›Full record

ArticleAtherosclerosis2020

Childhood risk factors and carotid atherosclerotic plaque in adulthood: The Cardiovascular Risk in Young Finns Study.

Juhani S Koskinen, Ville Kytö, Markus Juonala, Jorma S A Viikari, Jaakko Nevalainen, Mika Kähönen, Terho Lehtimäki, Nina Hutri-Kähönen, Tomi Laitinen, Päivi Tossavainen and 3 more

Registry-linked trialOpen access · greenAbstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Atherosclerosis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07497776 (Atorvastatin Therapy in the Treatment of Dyslipidemia in Children With Steroid Sensitive Nephrotic Syndrome), which is not on this map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07497776 phase4completedstarted 2024, after this paper: background citation

Atorvastatin Therapy in the Treatment of Dyslipidemia in Children With Steroid Sensitive Nephrotic Syndrome

Ran2024Enrolled100Registered outcomes1Posted comparisons0ConditionsDyslipidaemiaArmsAtorvastatin
Open the trial in the graph
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it, 82 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 2 countries.

Juhani S KoskinenResearch Center of Applied and Preventive Cardiovascular Medicine, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland; Division of Medicine, Turku University Hospital, Kiinamyllynkatu 4-8, 20521, Turku, Finland; Department of Medicine, Satakunta Central Hospital, Sairaalantie 3, 28500, Pori, Finland. Electronic address: jskosk@utu.fi.
Ville KytöResearch Center of Applied and Preventive Cardiovascular Medicine, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland; Heart Centre, Turku University Hospital, Hämeentie 11, 20521, Turku, Finland.
Markus JuonalaResearch Center of Applied and Preventive Cardiovascular Medicine, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland; Division of Medicine, Turku University Hospital, Kiinamyllynkatu 4-8, 20521, Turku, Finland; Department of Medicine, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland.
Jorma S A ViikariResearch Center of Applied and Preventive Cardiovascular Medicine, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland; Division of Medicine, Turku University Hospital, Kiinamyllynkatu 4-8, 20521, Turku, Finland; Department of Medicine, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland.
Jaakko NevalainenFaculty of Social Sciences, University of Tampere, Kalevantie 5, 33100, Tampere, Finland.
Mika KähönenDepartment of Clinical Physiology, University of Tampere, Arvo Ylpön katu 34, 33520, Tampere, Finland; Faculty of Medicine and Health Technology, University of Tampere, Arvo Ylpön katu 34, 33520, Tampere, Finland; Finnish Cardiovascular Research Center Tampere, University of Tampere, Kalevantie 4, 33100, Tampere, Finland.
Terho LehtimäkiFaculty of Medicine and Health Technology, University of Tampere, Arvo Ylpön katu 34, 33520, Tampere, Finland; Finnish Cardiovascular Research Center Tampere, University of Tampere, Kalevantie 4, 33100, Tampere, Finland; Department of Clinical Chemistry, University of Tampere, Arvo Ylpön katu 34, 33520, Tampere, Finland; Fimlab Laboratories, Arvo Ylpön katu 4, 33520, Tampere, Finland.
Nina Hutri-KähönenDepartment of Pediatrics, Tampere University Hospital, Teiskontie 35, 33520, Tampere, Finland.
Tomi LaitinenDepartment of Clinical Physiology, Kuopio University Hospital, Puijonlaaksontie 2, 70210, Kuopio, Finland.
Päivi TossavainenDepartment of Pediatrics, Oulu University Hospital, Kajaanintie 50, 90220, Oulu, Finland; PEDEGO Research Unit and Medical Research Center Oulu, University of Oulu, Aapistie 5 A, 90220, Oulu, Finland.
Eero JokinenDepartment of Pediatrics, University of Helsinki, Stenbäckinkatu 11, 00290, Helsinki, Finland; Hospital for Children and Adolescents, Helsinki University Hospital, Stenbäckinkatu 9, 00290, Helsinki, Finland.
Costan G MagnussenResearch Center of Applied and Preventive Cardiovascular Medicine, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland; Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool St, Hobart, TAS, 7000, Australia.
Olli T RaitakariResearch Center of Applied and Preventive Cardiovascular Medicine, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland; Department of Clinical Physiology and Nuclear Medicine, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland; Centre for Population Health Research, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland.
University of Turku · FITampere University of Applied Sciences · FIKuopio University Hospital · FIOulu University Hospital · FITampere University · FITampere University Hospital · FIUniversity of Helsinki · FIUniversity of Tasmania · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsCarotid plaque is a specific sign of atherosclerosis and adults with carotid plaque are at increased risk for cardiovascular outcomes. Atherosclerosis has roots in childhood and pediatric guidelines provide cut-off values for cardiovascular risk factors. However, it is unknown whether these cut-offs predict adulthood advanced atherosclerosis.

methodsThe Cardiovascular Risk in Young Finns Study is a follow-up of children that begun in 1980 when 2653 participants with data for the present analyses were aged 3-18 years. In 2001 and 2007 follow-ups, in addition to adulthood cardiovascular risk factors, carotid ultrasound data was collected. Long-term burden, as the area under the curve, was evaluated for childhood (6-18 years) risk factors. To study the associations of guideline-based cut-offs with carotid plaque, both childhood and adult risk factors were classified according to clinical practice guidelines.

resultsCarotid plaque, defined as a focal structure of the arterial wall protruding into lumen >50% compared to adjacent intima-media thickness, was present in 88 (3.3%) participants. Relative risk for carotid plaque, when adjusted for age and sex, was 3.03 (95% CI, 1.76-5.21) for childhood dyslipidemia, 1.51 (95% CI, 0.99-2.32) for childhood elevated systolic blood pressure, and 1.93 (95% CI, 1.26-2.94) for childhood smoking. Childhood dyslipidemia and smoking remained independent predictors of carotid plaque in models additionally adjusted for adult risk factors and family history of coronary heart disease. Carotid plaque was present in less than 1% of adults with no childhood risk factors.

conclusionsFindings reinforce childhood prevention efforts and demonstrate the utility of guideline-based cut-offs in identifying children at increased risk for adulthood atherosclerosis.

Indexed as

AdolescentBlood PressureCardiovascular DiseasesCarotid ArteriesCarotid Artery DiseasesCarotid Intima-Media ThicknessChildChild, PreschoolDisease ProgressionFemaleFinlandHeart Disease Risk FactorsHumansIncidenceMalePlaque, AtheroscleroticArea under the curve – Childhood risk factor long-term burdenAtherosclerosisCardiovascular risk factor cut-offsCarotid atherosclerotic plaqueChildhood cardiovascular risk factors

Identifiers

PMID31830725
OpenAlexW2991256540

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.